• 1. Design, synthesis and biological evaluation of 4-phenoxy-pyridine/pyrimidine derivatives as dual VEGFR-2/c-Met inhibitors
  Feiyi Yang,Qian Zhang,Qiuyan Guo,Qingshan Pan,Chunping Wen,Xinya Lv,Wufu Zhu,Pengwu Zheng New J. Chem. 2022 46 12651
• 2. Regioselectivity in the lithiation of methyl-substituted thiazole- and oxazole-carboxylic acids and carboxamides: general methods for the elaboration of trisubstituted thiazoles and oxazoles
  Philip Cornwall,Colin P. Dell,David W. Knight J. Chem. Soc. Perkin Trans. 1 1991 2417
• 3. Cationic, luminescent cyclometalated iridium(iii) complexes based on substituted 2-phenylthiazole ligands
  Emily C. Stokes,Emily E. Langdon-Jones,Lara M. Groves,James A. Platts,Peter N. Horton,Ian A. Fallis,Simon J. Coles,Simon J. A. Pope Dalton Trans. 2015 44 8488
• 4. Synthetic approaches and functionalizations of imidazo[1,2-a]pyrimidines: an overview of the decade
  Richa Goel,Vijay Luxami,Kamaldeep Paul RSC Adv. 2015 5 81608
• 5. Thiazole-based aminopyrimidines and N-phenylpyrazolines as potent antimicrobial agents: synthesis and biological evaluation
  Konstantinos Liaras,Athina Geronikaki,Jasmina Glamo?lija,Ana ?iri?,Marina Sokovi? Med. Chem. Commun. 2014 5 915

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles 2,4-disubstituted thiazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles 2,4-disubstituted thiazoles

Recent Advances in the Study of 4-Methyl-2-phenylthiazole (CAS: 1826-17-1) in Chemical Biology and Pharmaceutical Research

4-Methyl-2-phenylthiazole (CAS: 1826-17-1) is a heterocyclic compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by a thiazole ring substituted with a phenyl group and a methyl group, has been the subject of numerous studies aimed at exploring its biological activities, synthetic pathways, and therapeutic potential. The latest research highlights its role as a versatile scaffold in drug discovery, particularly in the development of anti-inflammatory, antimicrobial, and anticancer agents.

Recent studies have focused on the synthesis and optimization of 4-Methyl-2-phenylthiazole derivatives to enhance their pharmacological properties. For instance, a 2023 study published in the Journal of Medicinal Chemistry demonstrated that certain derivatives of this compound exhibit potent inhibitory effects on cyclooxygenase-2 (COX-2), a key enzyme involved in inflammatory processes. The researchers employed molecular docking and in vitro assays to identify the most promising candidates, paving the way for further preclinical evaluations.

In addition to its anti-inflammatory potential, 4-Methyl-2-phenylthiazole has shown promise as an antimicrobial agent. A 2022 study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of this compound exhibited significant activity against a range of Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). The study attributed this activity to the compound's ability to disrupt bacterial cell membrane integrity, suggesting a novel mechanism of action that could be exploited to combat antibiotic-resistant pathogens.

The anticancer potential of 4-Methyl-2-phenylthiazole has also been a focal point of recent research. A 2023 paper in European Journal of Medicinal Chemistry explored the compound's ability to induce apoptosis in cancer cells by targeting specific signaling pathways, such as the PI3K/Akt/mTOR axis. The study highlighted the compound's selectivity for cancer cells over normal cells, a critical factor in reducing off-target effects and improving therapeutic outcomes. These findings underscore the potential of 4-Methyl-2-phenylthiazole as a lead compound for the development of targeted cancer therapies.

Beyond its pharmacological applications, 4-Methyl-2-phenylthiazole has also been investigated for its role in chemical biology. A 2023 study in ACS Chemical Biology utilized this compound as a fluorescent probe to study protein-ligand interactions in real time. The researchers demonstrated that the compound's unique photophysical properties make it an excellent tool for visualizing dynamic biological processes, offering new insights into cellular mechanisms and drug-target interactions.

In conclusion, the latest research on 4-Methyl-2-phenylthiazole (CAS: 1826-17-1) highlights its multifaceted potential in chemical biology and pharmaceutical research. From its anti-inflammatory and antimicrobial properties to its applications in cancer therapy and chemical probes, this compound continues to be a valuable asset in the quest for novel therapeutics and biological tools. Future studies are expected to further elucidate its mechanisms of action and optimize its derivatives for clinical applications, solidifying its place in the forefront of modern drug discovery.

• 2227-61-4(4-Phenyl-2-(p-tolyl)thiazole)
• 1826-14-8(Thiazole, 2,4-diphenyl-)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)